|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investment in real estate: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Land improvements | ||||||||||||||||||||
| Buildings and other depreciable property | ||||||||||||||||||||
| Investment in real estate | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net investment in real estate | ||||||||||||||||||||
| Cash and restricted cash | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Investment in unconsolidated joint ventures | ||||||||||||||||||||
| Deferred commission expense | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||||
| Term loans, net | ||||||||||||||||||||
| Unsecured line of credit | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Deferred membership revenue | ||||||||||||||||||||
| Total deferred membership revenue | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Rents and other customer payments received in advance and security deposits | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 10,000,000 shares authorized as of September 30, 2026 and December 31, 2025; none issued and outstanding. | ||||||||||||||||||||
| Common stock, $0.01 par value, 600,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 194,068,205 and 193,835,561 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Distributions in excess of accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive income/(loss) | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Non-controlling interests – Common OP Units | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
